about
Characteristics and determinants of knowledge transfer policies at universities and public institutions in medical research--protocol for a systematic review of the qualitative research literatureWorld health dilemmas: Orphan and rare diseases, orphan drugs and orphan patientsA review of the health and economic implications of patent protection, with a specific focus on ThailandBeyond access to medicines: Eliciting high-income country support for a new global health research and development paradigmTrends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysisTrade liberalization and tuberculosis incidence: a longitudinal multi-level analysis in 22 high burden countries between 1990 and 2010Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature.Levels of spending and resource allocation to HIV programs and services in Latin America and the CaribbeanPatenting of university and non-university public research organisations in Germany: evidence from patent applications for medical research results."Trade policy, not morals or health policy": the US Trade Representative, tobacco companies and market liberalization in ThailandScaling up chronic disease prevention interventions in lower- and middle-income countriesManaging the pursuit of health and wealth: the key challenges.Trade and health: an agenda for actionBasic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.The ethics of intellectual property rights in an era of globalization.Big Events and Risks to Global Substance Using Populations: Unique Threats and Common Challenges.The high price of "free" trade: U.S. trade agreements and access to medicines.The Trans-Pacific Partnership: Should We "Fear the Fear"? Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?"Trade in medicines and the public's health: a time series analysis of import disruptions during the 2015 India-Nepal border blockadeRegulatory and logistical issues influencing access to antineoplastic and supportive care medications for children with cancer in developing countries.Consumers' perception of generic substitution in Iran.The right to health and medicines: the case of recent multilateral negotiations on public health, innovation and intellectual property.The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries.Promising Trends in Access to Medicines
P2860
Q26796735-635F4AD4-16EC-4868-B8DC-6054BCEF64EFQ26826936-87DCBEA8-7F48-4878-9B19-A19D06AEABE9Q27015946-4EB97576-9A6E-4C19-8EF0-F18E6E31ABFAQ27026462-D447245B-D416-4ABB-9F53-3B819FB66FE6Q28478773-F290B5BD-5560-4D51-A3DA-D516AAE7AF61Q30391740-997B4AB2-5D8A-47F5-93A1-AAD122DA81D7Q30850771-6D8B12EE-F754-44E0-B7D8-4D9FB038A55DQ31027621-22BA1B4B-BB2D-465E-BA67-C627F39BBB7CQ33761367-AAA0CEF4-CF7F-439B-96F3-B8D81B477649Q35100285-A2E33F15-8EDF-4B05-96FE-E16ED8CA1BB6Q36939475-FF40B6E9-AF3D-415C-BB2B-A617CFA633A1Q37305307-812F1B69-0C03-4951-9B13-B18DB4D19B9DQ37305311-6D3A84AC-421E-4046-83AC-CFDADD04EAF5Q37794235-6044DE6E-AA97-41AD-BA17-7A1AAED28692Q38180466-D9F0FDDC-560B-47C1-90F7-809275141EDFQ38365819-A7CDB133-9AD8-4C97-959D-E70DDE1882C0Q39436048-A0DF1B65-67A3-43D3-90B7-F97E50EE51E0Q39570860-E230BFA8-1BFA-4B30-9E48-9EFB29EEE3F3Q41501332-710E88AF-0CDC-45BD-B812-EE7EB1870911Q46758549-A2639716-647B-4C48-A6E5-C5193596206FQ47675163-3F6AF031-803F-48F4-9DA6-E50B499D074AQ51736368-886EDA37-B13C-41B5-983D-54CB01C72C98Q54941435-F43FACC4-7253-4B76-9C41-A16B6F07E088Q57325190-F64B2652-CE7A-43D4-97E2-EEB03ECBC654
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Trade, TRIPS, and pharmaceuticals.
@en
Trade, TRIPS, and pharmaceuticals.
@nl
type
label
Trade, TRIPS, and pharmaceuticals.
@en
Trade, TRIPS, and pharmaceuticals.
@nl
prefLabel
Trade, TRIPS, and pharmaceuticals.
@en
Trade, TRIPS, and pharmaceuticals.
@nl
P2093
P1433
P1476
Trade, TRIPS, and pharmaceuticals.
@en
P2093
Carlos Correa
Cecilia Oh
Richard D Smith
P304
P356
10.1016/S0140-6736(08)61779-1
P407
P577
2009-01-21T00:00:00Z